Yuyu Pharma Inc Total Liabilities

Latest as of September 2025: ₩63.32 Billion KRW ≈ $42.91 Million USD

Yuyu Pharma Inc total liabilities. Based on the latest financial reports, Yuyu Pharma Inc (000227) has total liabilities worth ₩63.32 Billion KRW (≈ $42.91 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Yuyu Pharma Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Yuyu Pharma Inc (2014–2024)

Total liabilities of Yuyu Pharma Inc from 2014 to 2024. This chart illustrates how Yuyu Pharma Inc's total liabilities have evolved over time, based on quarterly financial data. Explore Yuyu Pharma Inc (000227) investment intensity to see how much of total assets are deployed in long-term investments.

Yuyu Pharma Inc Competitors by Total Liabilities

The table below lists competitors of Yuyu Pharma Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Desert Gold Ventures Inc V:DAU	Canada	CA$226.73K
Kinetiko Energy Ltd AU:KKO	Australia	AU$725.28K
TREJHARA SOLUTIONS LIMITED NSE:TREJHARA	India	Rs981.24 Million
Harrisons Malayalam Limited NSE:HARRMALAYA	India	Rs3.37 Billion
Shanghai Kai Kai Industry Co Ltd B SHG:900943	China	$878.36 Million
Payment Financial Technologies Ltd TA:PMNT	Israel	ILA133.38 Million
Better World Green Public Company Limited BK:BWG	Thailand	฿2.54 Billion
InBioGen Co Ltd KO:101140	Korea	₩2.44 Billion

Liability Composition Analysis (2014–2024)

This chart breaks down Yuyu Pharma Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Yuyu Pharma Inc.

Liquidity & Leverage Metrics

Yuyu Pharma Inc Total Liabilities Ratios Explained

Yuyu Pharma Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.77	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.49	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.31	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Yuyu Pharma Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Yuyu Pharma Inc (2014–2024)

The table below shows the annual total liabilities of Yuyu Pharma Inc from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩72.62 Billion ≈ $49.22 Million	-6.72%
2023-12-31	₩77.86 Billion ≈ $52.76 Million	+8.39%
2022-12-31	₩71.83 Billion ≈ $48.68 Million	+11.71%
2021-12-31	₩64.30 Billion ≈ $43.58 Million	+69.82%
2020-12-31	₩37.86 Billion ≈ $25.66 Million	-19.73%
2019-12-31	₩47.17 Billion ≈ $31.97 Million	-2.44%
2018-12-31	₩48.35 Billion ≈ $32.77 Million	+25.08%
2017-12-31	₩38.66 Billion ≈ $26.20 Million	+17.11%
2016-12-31	₩33.01 Billion ≈ $22.37 Million	+7.88%
2015-12-31	₩30.60 Billion ≈ $20.73 Million	+2.29%
2014-12-31	₩29.91 Billion ≈ $20.27 Million	--

About Yuyu Pharma Inc

KO:000227 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$32.56 Million

₩48.05 Billion KRW

Market Cap Rank

#23274 Global

#1591 in Korea

Share Price

₩8200.00

Change (1 day)

+0.12%

52-Week Range

₩6300.00 - ₩11670.00

All Time High

₩56262.57